Sphingolipid Metabolism in Cellular Signaling and Disease

Sphingolipids constitute a diverse class of membrane lipids that extend beyond structural roles to serve as pivotal regulators of cell fate, inflammation and intercellular communication. Central to this network are ceramides, sphingosine and their phosphorylated derivatives, which act as bioactive messengers in processes ranging from apoptosis and autophagy to immune modulation and vascular integrity. De novo synthesis begins with serine palmitoyltransferase and proceeds through ceramide synthases that generate species of varying acyl-chain length. These molecular variants localise to distinct subcellular compartments and engage specific enzymes and receptors, yielding a finely tuned signalling landscape. Dysregulation of sphingolipid flux has been implicated in inflammatory diseases, neurodegeneration, metabolic syndrome and cancer. Recent advances have illuminated how interleukin-10-dependent programmes of fatty acid desaturation constrain the accumulation of pro-inflammatory very-long-chain ceramides, how receptor-mediated sphingosine-1-phosphate gradients govern lymphocyte egress and how ceramide heterogeneity underpins selective engagement of downstream effectors. Understanding these interconnected pathways offers new avenues for therapeutic intervention.

Research from Nature Portfolio

Recent studies demonstrate that the anti-inflammatory cytokine interleukin-10 orchestrates a fatty acid desaturation programme that limits the build-up of saturated very-long-chain ceramides in innate immune cells. In the absence of interleukin-10 signalling, excess ceramides sustain aberrant activation of the transcription factor REL, driving a hyper-inflammatory gene signature. Genetic ablation of the specific ceramide synthase responsible for very-long-chain species restores metabolic balance and attenuates inflammation in vitro and in vivo. These findings reveal fatty acid homeostasis as a control node in sphingolipid metabolism and point to strategies for metabolic correction to resolve pathological inflammation.

Sphingolipid Metabolism in Cellular Signaling and Disease publication trend

The graph below shows the total number of articles in sphingolipid metabolism in cellular signaling and disease across all publications each year (not limited to Nature Index journals).

Technical terms

Sphingolipid: A class of lipids containing a sphingoid base, involved in membrane structure and cell signalling.

Ceramide: A central sphingolipid metabolite comprising a sphingoid base linked to a fatty acyl chain; a precursor for complex species and a bioactive messenger.

Sphingosine-1-phosphate (S1P): A phosphorylated sphingoid base that signals through G protein-coupled receptors to regulate cell migration, vascular tone and immunity.

Serine palmitoyltransferase (SPT): The rate-limiting enzyme initiating de novo sphingolipid synthesis by condensing serine and palmitoyl-CoA.

Ceramide synthase (CerS): A family of enzymes that N-acylate sphingoid bases with fatty acyl-CoAs of defined chain length, generating ceramide species.

Sphingosine kinase (SphK): An enzyme that phosphorylates sphingosine to produce S1P, thereby shifting the balance between pro-apoptotic and pro-survival signals.

References

1. IL-10 constrains sphingolipid metabolism to limit inflammation. Nature (2024).
2. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors*. Journal of Biological Chemistry (2002).
3. Many Ceramides*. Journal of Biological Chemistry (2011).
4. Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate*. Journal of Biological Chemistry (2004).
5. Bioactive sphingolipids: metabolism and function. Journal of Lipid Research (2008).